Lofexidine and desipramine: Interaction results in breakthrough opioid withdrawal symptoms

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International journal of psychiatry in clinical practice

• Publication date

  2002-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/136515002760276135PMID 24945207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

  1999cited by this paper
• Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.

  1996cited by this paper
• Stimulant withdrawal.

  1994cited by this paper
• Stimulant withdrawal : Withdrawal syndrome

  1994cited by this paper
• The development of a Short Opiate Withdrawal Scale (SOWS).

  1990cited by this paper
• Desipramine facilitation of initial cocaine abstinence.

  1989cited by this paper
• Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

  1986cited by this paper

• Lofexidine for opiate detoxification

  2004cites this paper
• Current Awareness: Pharmacoepidemiology and Drug Safety

  2003cites this paper
• Pharmacoepidemiology and drug safety.

  2003cites this paper
• Current awareness in human psychopharmacology.

  2003cites this paper